Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.04 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (hepatocytes) | 0.10 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 14 Parkinson's papers of 7,168 | 0.64 |
| pathways Reactome | 2 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 5611
Sealed predictions
- C9 in dopamine neurons, braak+0.07 (p 0.859) → +0.78 (p 0.012)receipt 5617
Swarm cases
receipt 5617: C9 in dopamine neurons, braak
- power
- full sample +0.47 (p 0.050, n 18), 95% CI +0.00 to +0.77. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.47 (p 0.050, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.47 (p 0.050, n 18). not the mix.
- skeptic
- leave-one-out range +0.39 to +0.68, sign flips 0; without severely affected donors +0.47 (p 0.050, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for C9 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts